Endothelin Receptor Antagonist class drugs

2 results
Zydus Lifesciences Limited
Travere Therapeutics, Inc.
Usage: FILSPARI is indicated for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression.